tradingkey.logo

Kestra Medical Technologies Ltd

KMTS
查看详细走势图
25.470USD
+0.350+1.39%
收盘 02/06, 16:00美东报价延迟15分钟
1.31B总市值
亏损市盈率 TTM

Kestra Medical Technologies Ltd

25.470
+0.350+1.39%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.39%

5天

+3.24%

1月

-4.28%

6月

+72.68%

今年开始到现在

-3.96%

1年

0.00%

查看详细走势图

操作建议

Kestra Medical Technologies Ltd当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力较大。当前估值合理,在医疗设备与耗材行业排名37/205位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价29.00。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Kestra Medical Technologies Ltd评分

相关信息

行业排名
37 / 205
全市场排名
125 / 4521
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看好

Kestra Medical Technologies Ltd亮点

亮点风险
Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
业绩增长期
公司处于发展阶段,最新年度总收入59.81M美元
估值合理
公司最新PE估值-9.23,处于3年历史合理位
机构加仓
最新机构持股50.34M股,环比增加1.70%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值1.27M

分析师目标

根据 7 位分析师
买入
评级
29.000
目标均价
+13.37%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Kestra Medical Technologies Ltd新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Kestra Medical Technologies Ltd简介

Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
公司代码KMTS
公司Kestra Medical Technologies Ltd
CEOWebster (Brian Daniel)
网址
KeyAI